Indegene Limited (BOM:544172)

India flag India · Delayed Price · Currency is INR
567.25
+28.80 (5.35%)
At close: Mar 27, 2025
-14.01%
Market Cap 138.42B
Revenue (ttm) 27.57B
Net Income (ttm) 3.84B
Shares Out n/a
EPS (ttm) 16.34
PE Ratio 36.06
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 22,337
Average Volume 40,056
Open 529.35
Previous Close 538.45
Day's Range 529.35 - 572.35
52-Week Range 468.90 - 736.60
Beta n/a
RSI 56.61
Earnings Date May 29, 2025

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor... [Read more]

Industry Commercial Physical and Biological Research
Founded 1998
Employees 4,367
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544172
Full Company Profile

Financial Performance

In 2023, Indegene's revenue was 25.90 billion, an increase of 12.29% compared to the previous year's 23.06 billion. Earnings were 3.37 billion, an increase of 26.53%.

Financial Statements

News

There is no news available yet.